Fondaparinux instructions for administration: Difference between revisions

Jump to navigation Jump to search
 
(7 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{CMG}}
#REDIRECT [[Fondaparinux#Administration and Monitoring]]


==Instructions for Administration==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration.
[[Category: Anticoagulants]]
 
Arixtra Injection is provided in a single dose, prefilled syringe affixed with an automatic needle protection system. Arixtra is administered by subcutaneous injection. It must not be administered by intramuscular injections. Arixtra is intended for use under a physician’s guidance. Patients may self-inject only if their physician determines that it is appropriate and with medical follow-up as necessary. Proper training in subcutaneous injection technique should be provided.
 
To avoid the loss of drug when using the pre-filled syringe, do not expel the air bubble from the syringe before the injection. Administration should be made in the fatty tissue, alternating injection sites (e.g., between the left and right anterolateral or the left and right posterolateral abdominal wall).
 
To administer Arixtra.
 
* Wipe the surface of the injection site with an alcohol swab.
 
* Twist the plunger cap and remove it.
 
* Hold the syringe with either hand and use your other hand to twist the rigid needle guard (covers the needle) counter-clockwise.
* Pull the rigid needle guard straight off the needle.
* Pinch a fold of skin at the injection site between your thumb and forefinger and hold it throughout the injection.
* Hold the syringe with your thumb on the top pad of the plunger rod and your next 2 fingers on the finger grips on the syringe barrel. Pay attention to avoid sticking yourself with the exposed needle

Latest revision as of 16:22, 21 July 2014